Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Does Institutional Memory Matter?

JACC. Heart failure·2017

Same author

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.

Journal of the American College of Cardiology·2017

Same author

Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure.

International journal of molecular sciences·2017

Same author

A Decade With Editorial Mentors: The Day They Dropped the Mic.

JACC. Heart failure·2017

Same author

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.

Cardiovascular drugs and therapy·2017

Same author

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.

Journal of the American College of Cardiology·2017

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

The new heart failure guidelines: strategies for implementation.

Christopher M O'Connor¹

¹Division of Clinical Pharmacology, Duke University Medical Center, Durham, NC 27705, USA. oconn002@mc.duke.edu <oconn002@mc.duke.edu>

American Heart Journal

|March 31, 2007

Summary

Many heart failure patients miss out on life-prolonging treatments due to a prescribing gap. Implementing systematic processes, like predischarge therapy initiation, can improve the use of evidence-based heart failure medications.

Related Experiment Videos

Last Updated: Jul 16, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Area of Science:

Cardiology
Clinical Pharmacy
Health Services Research

Background:

Life-prolonging therapies for heart failure are underutilized, creating a significant treatment gap.
Suboptimal prescribing rates for key heart failure medications (ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists) are a concern.
High mortality and morbidity associated with heart failure necessitate improved access to proven treatments.

Purpose of the Study:

To identify strategies for increasing the uptake of evidence-based therapies in heart failure patients.
To evaluate the effectiveness of predischarge therapy initiation and systematic process improvements in enhancing medication utilization.

Main Methods:

Review of existing literature on heart failure treatment utilization.
Analysis of data from registry initiatives implementing performance improvement systems.
Examination of predischarge therapy initiation strategies in acute coronary syndrome and heart failure populations.

Main Results:

Predischarge initiation of therapies has successfully increased utilization in acute coronary syndrome.
Predischarge beta-blockade initiation in heart failure is safe and improves use at 60 days.
Performance improvement systems in registries correlate with better evidence-based therapy prescribing.

Conclusions:

Systematic processes are effective in ensuring eligible heart failure patients receive appropriate evidence-based therapies.
Improving prescribing rates for heart failure medications is critical for enhancing clinical outcomes.
Targeted interventions, such as predischarge therapy initiation, can help close the treatment gap.